Sangamo Therapeutics

Sangamo Therapeutics

Focus:

Type: Public Corporation
Founded: 1995


Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

Leadership
Jeffrey Marrazzo
Founder


Financial Performance



Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2018
8M USD
Grant
2018
11M USD
Grant
Known Investors
Name
Type
HQ
Other Relevant Investments
*More data available at: [CB Insights] [CrunchBase] [PitchBook]

Related
News